Pharmafile Logo
Pharmafocus logo
Advanced Search

Nasal spray that relieves migraines in minutes approved by FDA

March 13, 2023
Medical Communications

Pfizer is planning to launch a fast-acting nasal spray that can relieve pain from migraines in as little as 15 …

News

Horizon Therapeutics announces real-world treatment results for Dysthyroid Optic Neuropathy drug

March 13, 2023
Medical Communications

Biopharma company Horizon Therapeutics has announced real-world treatment results for its Thyroid Eye Disease (TED) drug in patients with Dysthyroid …

News

Biotech centre focusing on gene therapies opens in Bristol, UK

March 10, 2023
Medical Communications

A new state-of-the-art facility named the Clinical Biotechnology Centre (CBC) is opening in Bristol, UK. It cost approximately £10m to …

News

FDA makes unusual ‘misinformation’ comment on Lucira’s EUA for COVID-19 and flu test

March 10, 2023
Sales and Marketing

The FDA has made a rare comment about what happened at Lucira Health’s Emergency Use Authorization (EUA) filing for its …

News

Acadia Pharmaceuticals awaits FDA decision for first-of-its-kind Rett syndrome drug

March 10, 2023
Research and Development

Acadia Pharmaceuticals is aiming to follow in the footsteps of Reata Pharmaceuticals, who won approval for its novel drug to …

News

FDA committee supports Roche’s lymphoma treatment

March 10, 2023
Medical Communications

 A committee at the FDA have voted in favour of Roche’s Polivy antibody drug targeting untreated diffuse large B cell …

News

FlyPharma Europe, Vienna: 2023 conference officially launched

March 9, 2023
Business Services

FlyPharma Europe, Vienna: 2023 conference officially launched   FlyPharma Conferences is pleased to announce its seventh event in Europe, which …

News
Press release

MSD presents Phase 3 data for its Investigational Activin Signaling Inhibitor, in Adults with Pulmonary Arterial Hypertension on Background Therapy

March 9, 2023
Business Services

LONDON, UK, March 6, 2023 – MSD (tradename of Merck & Co., Inc., Rahway, N.J., USA (NYSE: MRK)) today announced …

News
Press release

GSK’s RSV vaccine ready to launch

March 9, 2023
Sales and Marketing

GSK has announced that it is ready to launch its respiratory syncytial virus (RSV) vaccine in the US at some …

News

Eli Lilly & Co’s Alzheimer’s disease drug fails to stop disease decline

March 9, 2023
Research and Development

Eli Lilly & Co have today announced that its Alzheimer’s disease (AD) hopeful did not slow the progression of cognitive …

News

AstraZeneca shares positive results from Imfinzi trial

March 9, 2023
Research and Development

Pharma giant AstraZeneca has shared positive results from a phase 3 trial on Imfinzi, its resectable non-small cell lung cancer …

News

Respiree gets FDA clearance for cardio-respiratory wearable

March 9, 2023
Medical Communications

Respiree, a digital therapeutics start-up, has secured the 510(k) FDA clearance for its RS001 cardio-respiratory wearable.   RS001 is a …

News

New clinical trial aims to find new endometriosis treatment

March 8, 2023
Research and Development

A new clinical trial is set to begin shortly which will be a collaboration between the universities of Edinburgh, Aberdeen …

News

Abbott’s concussion-detecting blood test approved by FDA

March 8, 2023
Medical Communications

US-based Abbott, a medical technology company, has received FDA approval for its laboratory blood test which detects traumatic brain injury …

News

Hospital for Special Surgery reveals 3D surface topographic scan for scoliosis patients

March 8, 2023
Medical Communications

Researchers at New York City’s Hospital for Special Surgery (HSS) have found that using a 30-camera array, or 3dMD, can …

News

FDA grants de novo approval to Neuromod’s tinnitus device

March 8, 2023
Medical Communications

The FDA has granted de novo approval to Neuromod’s Lenire device which includes Bluetooth headphones, a handheld controller and the …

News

Redx Announces RXC004 Topline Data From a Phase 2 Monotherapy Module

March 8, 2023
Business Services

Alderley Park, UK, 8 March 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

POLB 001 patent portfolio strengthened through granting of US patent

March 8, 2023
Business Services

8 March 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’),  a leading infectious disease focused biopharmaceutical …

News
Press release

Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases

March 7, 2023
Business Services

Parma, Italy and Solna, Sweden, March 7th, 2023 – Chiesi Farmaceutici S.p.A (“Chiesi Group”) and Affibody AB (“Affibody”) today announced …

News
Press release

Funding to increase access to early phase clinical trials given to Yale Cancer Center

March 7, 2023
Sales and Marketing

Yale Cancer Center has announced it has received collaborative funding aiming to support and increase access to early phase clinical …

News
The Gateway to Local Adoption Series

Latest content

MRM Health’s ulcerative colitis treatment receives FDA Investigational New Drug clearance

January 27, 2026

Crystalys Therapeutics appoints Justin Thacker as Chief Financial Officer

January 27, 2026

Rentschler Biopharma appoints Uwe Buecheler as interim CEO

January 26, 2026

Sandoz’ Ondibta receives European Commission approval for diabetes

January 26, 2026

Complement Therapeutics’ geographic atrophy treatment receives FDA Fast Track designation

January 22, 2026